The Capital Group Companies, Inc. - Net Worth and Insider Trading
The Capital Group Companies, Inc. Net Worth
The estimated net worth of The Capital Group Companies, Inc. is at least $366 Million dollars as of 2024-11-13. The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc and owns about 11,577,388 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $366 Million. Details can be seen in The Capital Group Companies, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that The Capital Group Companies, Inc. has not made any transactions after 2023-07-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, The Capital Group Companies, Inc. owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .
Insider Ownership Summary of The Capital Group Companies, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2023-07-31 | 2201 Interest of corporation controlled by you |
The Capital Group Companies, Inc. Latest Holdings Summary
The Capital Group Companies, Inc. currently owns a total of 1 stock. The Capital Group Companies, Inc. owns 11,577,388 shares of CanSino Biologics Inc (HKSE:06185) as of July 31, 2023, with a value of $366 Million.
Latest Holdings of The Capital Group Companies, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2023-07-31 | 11,577,388 | 31.65 | 366,424,330 |
Holding Weightings of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, The Capital Group Companies, Inc. has made a total of 26 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years, including 5 buys and 21 sells. The most-recent trade in CanSino Biologics Inc is the sale of 476,600 shares on July 31, 2023, which brought The Capital Group Companies, Inc. around $14 Million.
Insider Trading History of The Capital Group Companies, Inc.
- 1
The Capital Group Companies, Inc. Trading Performance
GuruFocus tracks the stock performance after each of The Capital Group Companies, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by The Capital Group Companies, Inc. is -46.93%. GuruFocus also compares The Capital Group Companies, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by The Capital Group Companies, Inc. within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how The Capital Group Companies, Inc.'s insider trading performs compared to the benchmark.
Performance of The Capital Group Companies, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.76 | | | | | |
| Relative Return to S&P 500(%) | -12.42 | | | | | |
The Capital Group Companies, Inc. Ownership Network
Ownership Network List of The Capital Group Companies, Inc.
Ownership Network Relation of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Owned Company Details
What does CanSino Biologics Inc do?
Who are the key executives at CanSino Biologics Inc?
The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include Jpmorgan Chase & Co. , Citigroup Inc. , and 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. .
CanSino Biologics Inc (HKSE:06185) Insider Trades Summary
Over the past 18 months, The Capital Group Companies, Inc. made 9 insider transaction in CanSino Biologics Inc (HKSE:06185) with a net sale of 6,747,000. Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net purchase of 360,400 shares made by Jpmorgan Chase & Co. ,
In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,168,200 shares of CanSino Biologics Inc (HKSE:06185) were sold and 781,600 shares were bought by its insiders, resulting in a net sale of 6,386,600 shares.
CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.
CanSino Biologics Inc Insider Transactions
The Capital Group Companies, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for The Capital Group Companies, Inc.. Currently GuruFocus does not have mailing address information for The Capital Group Companies, Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
